ATR (phospho Thr1989) antibody
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0446485-V3
- Awardee
- GENETEX INC
- Contracting organization
- University of Virginia
- Cumulative value
- $169.00
About this award
The University of Virginia awarded contract A207_PO-0446485-V3 to GENETEX INC on August 8, 2026, for the supply of research-grade antibodies. The prime contractor will deliver 169 vials of ATR (Ataxia Telangiectasia and Rad3-related) phospho Threonine 1989 antibody at a unit price of $1 per vial, resulting in a cumulative contract value of $169. Delivery is designated to the buyer, with the University of Virginia serving as the contracting organization.
This procurement represents a straightforward materials supply agreement within the Commonwealth of Virginia. The antibody product specified is a phosphorylated protein detection reagent commonly utilized in molecular biology and research applications. The contract terms reflect a limited-scope acquisition with a defined quantity and unit pricing structure typical of laboratory supply agreements executed by academic research institutions.
Line items
| Item | Total |
|---|---|
| ATR (phospho Thr1989) antibody | $169.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0446485-V3?
Contract A207_PO-0446485-V3 was awarded to GENETEX INC by University of Virginia on August 8, 2026.
How much is contract A207_PO-0446485-V3 worth?
Its cumulative value is $169.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award